Review of cases of zoophilia in patients with Parkinson's disease

被引:1
|
作者
Campo-Arias, Adalberto [1 ]
Castillo-Tamara, Edgard E. [2 ]
Herazo, Edwin [3 ]
机构
[1] Univ Magdalena, Fac Ciencias Salud, Santa Marta, Colombia
[2] Univ Sinu, Cartagena, Colombia
[3] Inst Invest Comportamiento Humano, Bogota, Colombia
关键词
Adverse effects; Dopamine agonists; Paraphilic disorders; Parkinson's disease; Review; Sexual behaviors; DOPAMINERGIC THERAPY; HYPERSEXUALITY; PARAPHILIAS; BESTIALITY; DISORDERS; BEHAVIORS; AGONISTS; ANIMALS; PEOPLE;
D O I
10.33588/rn.6704.2018056
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Parkinson's disease (PD) is characterized by motor symptoms such as bradykinesia, rigidity, alteration of postural reflexes and tremor at rest and other non-motor symptoms such as changes in sleep patterns and sexual behavior. However, little is known about paraphilic sexual behaviors. Aim. To summarize the number of cases of zoophilic behaviors in patients with PD between January 2000 and December 2017. Development. A review was carried out in PubMed, Scopus and Virtual Health Library. Eleven articles were identified by title; six were excluded because they did not present cases related to zoophilic behavior. We found five cases of men, usually with PD of several years of course, taking dopamine agonists and who presented the zoophilic behaviors followed increasing of the dose. The zoophilic behaviors decreased with reducing doses of dopamine agonists and taking atypical antipsychotic such as clozapine or quetiapine. Conclusions. It is limited the case reports of zoophilic behaviors in patients with PD. The patients reported are men in whom the dose of dopamine agonists was increased. It is important that the clinical follow-up of patients with PD disease includes a careful review of sexual behaviors including those of the paraphilic spectrum.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [41] Genetic substrates of psychosis in patients with Parkinson's disease: A critical review
    Lenka, Abhishek
    Arumugham, Shyam Sundar
    Christopher, Rita
    Pal, Pramod Kumar
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 364 : 33 - 41
  • [42] Depression in Parkinson's disease - a review
    Wermuth, L.
    Bech, P.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (05): : 360 - 360
  • [43] Opicapone: A Review in Parkinson's Disease
    Scott, Lesley J.
    DRUGS, 2016, 76 (13) : 1293 - 1300
  • [44] Fatigue in Parkinson's disease: a review
    Friedman, Joseph H.
    Brown, Richard G.
    Comella, Cynthia
    Garber, Carol E.
    Krupp, Lauren B.
    Lou, Jau-Shin
    Marsh, Laura
    Nail, Lillian
    Shulman, Lisa
    Taylor, C. Barr
    MOVEMENT DISORDERS, 2007, 22 (03) : 297 - 308
  • [45] Opicapone: A Review in Parkinson’s Disease
    Lesley J. Scott
    CNS Drugs, 2021, 35 : 121 - 131
  • [46] Review: management of Parkinson's disease
    Pedrosa, David J.
    Timmermann, Lars
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 321 - 340
  • [47] Enterobacteriaceae and Parkinson's Disease: A Review
    Grosse, C.
    Miller, K.
    Deragon, K.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2017, 32 (06)
  • [48] Depression in Parkinson's disease - a review
    Lieberman, A
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (01): : 1 - 8
  • [49] "Advanced" Parkinson's disease: A review
    Aslam, Sana
    Manfredsson, Fredric
    Stokes, Ashley
    Shill, Holly
    PARKINSONISM & RELATED DISORDERS, 2024, 123
  • [50] Effect of Medication Review on Reported Symptoms in Parkinson's disease Patients
    Stuijt, C.
    Laar, T.
    MOVEMENT DISORDERS, 2019, 34 : S299 - S299